PharmiWeb.com (press release) The company pipeline includes two clinical stage products CPX-351 (a liposomal formulation of cytarabine:daunorubicin) for the treatment of acute myeloid leukemia and CPX-1 (a liposomal formulation of irinotecan :floxuridine) for the treatment of ... and more »
Exponent-telegram Do not take REYATAZ (atazanavir sulfate) with the following medicines due to potential for serious side effects:Camptosar® ( irinotecan ), Crixivan® (indinavir), Mevacor®(lovastatin), Zocor® (simvastatin), Uroxatral® (alfuzosin), or Revatio® (sildenafil).
